Back to search
FDAFDA · Food and drugs·Recall number D-0130-2019

Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450

Published October 31, 2018 · Recall initiated: September 25, 2018

Summary

FDA records drug Class II recall D-0130-2019, published October 31, 2018 and initiated September 25, 2018. Recalling firm: RXQ Compounding LLC; Status: Terminated; Reported quantity: 395 vials; Lot: Lot# 04042018:58, Exp 10/17/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RXQ Compounding LLC
Distributor
U.S.A. nationwide
Lot
Lot# 04042018:58, Exp 10/17/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450 recalled?

Yes. FDA published recall D-0130-2019 on October 31, 2018. Reported hazard: Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.

What should I do if I have this product?

Voluntary: Firm initiated · Letter